First quarter commentary.
Our first letter of 2026, how the portfolio performed, where we added and trimmed, and what we're watching from here.Read the letter →
We don't invest in weapons, vice, or the businesses quietly enabling them, and we still aim to beat the market. Separately managed accounts for accredited investors who want their capital to reflect their principles.
Manufacturers, component suppliers, and the software vendors that make modern warfare possible.
Surveillance firms, private prisons, and companies like Cadence Design Systems and Cognizant that customize their offerings for aerospace and defense customers.
Businesses whose core economics depend on addiction, compulsion, or the erosion of household balance sheets.
Producers, the platforms that monetize them, and companies that charge punitive interest or lend heavily to likely-delinquent customers.
Excluding these categories isn't charity. Weapons programs face regulatory whiplash. Vice categories face shrinking social license and a generational shift in how capital chooses to be deployed.
What looks like a narrow screen today often looks like prudence in a decade. We think morality and compounding are compatible.
Every portfolio begins with a values-first exclusion. We don't screen at the edges; we screen at the gate.
In our active strategies, we buy businesses we believe are inefficiently priced, positions we expect can double over a patient hold.
We intend to own our investments for extended periods. Returns can be volatile, and we are candid with clients that this is part of the investment proposition.
Exposure to the U.S. economy, with companies that violate our principles removed. Broad participation, without funding what you wouldn't fund yourself.
A mix of ETFs and single stocks, without style, market cap, or cash constraints, designed to adjust as market conditions dictate.
Small and micro cap companies with significant growth potential, an underfollowed segment where careful work can be rewarded. Capacity constrained to $20mm.
If you wouldn't lend your name to a business, you shouldn't invest in it either. Everything we do starts there.
Basil has spent nearly two decades investing in public markets. Before founding White Brook Capital in 2016, he was a Senior Analyst at MSF Capital, a value-oriented hedge fund. Earlier in his career, he was the telecom analyst at BBT Capital Management and an investment banking analyst in the Technology, Media, and Telecom group at JPMorgan.
Our first letter of 2026, how the portfolio performed, where we added and trimmed, and what we're watching from here.Read the letter →
Our full-year look back at 2025, what worked, what didn't, and what we're watching going into next year.Read the letter →
How the portfolio performed, where we added and trimmed, and the macro backdrop through the third quarter.Read the letter →
White Brook Capital accepts new client relationships on a considered basis. If your values and your portfolio feel like they belong to different people, we should talk.
Request a Conversation